InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the full record of transactions filed by Liang Howard, Chief Financial Officer. Officer active across 1 companies, notably BeiGene, Ltd.. In total, 6 filings have been recorded. Total volume traded: €916k. The latest transaction was filed on 28 June 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€136,467446 shares@ €305.979529.8% of flow
American Depositary Shares
SEC:0001651308-21-000138·
€136,467446 shares@ €305.97950.0004% mcap14.9% of flow
American Depositary Shares
SEC:0001651308-21-000138:0·
€132,945486 shares@ €273.550429.0% of flow
American Depositary Shares
SEC:0001651308-21-000125·
€132,945486 shares@ €273.55040.0004% mcap14.5% of flow
American Depositary Shares
SEC:0001651308-21-000125:0·
€188,789650 shares@ €290.44470.0006% mcap20.6% of flow
American Depositary Shares
SEC:0001651308-21-000109:0·
€188,789650 shares@ €290.444741.2% of flow
American Depositary Shares
SEC:0001651308-21-000109·
6 of 6 declarations
About Liang Howard
Howard Liang is the Chief Financial Officer and Chief Strategy Officer at BeiGene, Ltd. In this role, he is responsible for financial management and strategy of the company, playing a key role in its growth and development.
